Hokuyaku Takeyama Holdings,Inc. (SPSE: 3055)

Market Cap	17.63B
Revenue (ttm)	280.69B
Net Income (ttm)	2.33B
Shares Out	21.07M
EPS (ttm)	108.41
PE Ratio	7.72
Forward PE	n/a
Dividend	20.00 (2.39%)
Ex-Dividend Date	Mar 28, 2025

Volume	100
Open	830.00
Previous Close	850.00
Day's Range	830.00 - 830.00
52-Week Range	734.00 - 1,052.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 6, 2025

About Hokuyaku Takeyama Holdings,Inc.

Hokuyaku Takeyama Holdings,Inc. engages in the wholesale of pharmaceutical products in Japan. It also sells medical devices, such as treatment/facility equipment, image diagnostic equipment, optical equipment, artificial organ-related equipment, biological information-related equipment, physical therapy equipment, and examination equipment, as well as general-purpose products, such as syringes and orthopedic surgery. In addition, the company operates pharmacies in Hokkaido; and provides nursing care services, welfare equipment, care plans, day ...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 2006
• Employees: 1,601
• Stock Exchange: Sapporo Stock Exchange
• Ticker Symbol: 3055

Financial Performance

In 2023, Hokuyaku Takeyama Holdings,Inc.'s revenue was 275.36 billion, an increase of 5.11% compared to the previous year's 261.98 billion. Earnings were 2.18 billion, a decrease of -20.30%.